Krka has launched Flovuxin, a fast-acting, single-dose, injectable solution for bovine respiratory disease (BRD) caused by Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis and Histophilus somni, associated with pyrexia.

Krka’s Farm Key Account Manager Charlotte Read said: “BRD remains a priority issue on farm and advising farmers on the management of BRD risks, and treatment options when needed, is a key task for farm vets.

"Flovuxin’s combined formulation is a high efficacy BRD treatment acting within six hours1, to improve treatment outcomes.” 

Reference

  1. Julien Thiry, Laura Elvira Partida, Juan Vicente GonzálezMartín, Eric Pagot, Florian Voisin, Hubert Theys, Guillaume Lequeux, Allan Weingarten, Vincent de Haas (2014); Treatment of naturally occurring bovine respiratory disease in juvenile calves with a single administration of a florfenicol plus flunixin meglumine formulation; The Veterinary record 174(17)